Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Department of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Eur Urol Focus. 2021 Jan;7(1):172-177. doi: 10.1016/j.euf.2019.08.007. Epub 2019 Aug 30.
Current European Association of Urology guidelines suggest investigation of erectile dysfunction (ED) among patients with lower urinary tract symptoms (LUTS) whenever there is a clinical suspicion.
To assess factors predictive of ED, which may drive the need for a clinical assessment in men only presenting for LUTS.
DESIGN, SETTING, AND PARTICIPANTS: Data from 914 men presenting for LUTS at a single-center outpatient clinic and without a previous diagnosis of ED were analyzed.
All patients completed the International Prostatic Symptom Score (IPSS) and the International Index of Erectile Function-erectile function (IIEF-EF) questionnaires.
Logistic regression analyses tested potential predictors of ED and severe ED. The accuracy of the predictive models was assessed, and decision curve analyses (DCAs) tested their clinical benefit.
The median baseline IPSS score was 12 (7-19). IIEF-EF scores suggestive of unreported ED were observed in 503 (55%) patients; of all, 251 (27%) men showed severe ED. At logistic regression analysis, age (odds ratio [OR]: 1.04; p<0.001), IPSS score (OR: 1.04; p<0.001), diabetes mellitus (OR: 2.37; p=0.02), and smoking history (OR 1.36; p=0.03) were associated with unreported ED, after accounting for body mass index, hypertension, other cardiovascular diseases, and dyslipidemia. The same factors were associated with severe ED (all p≤0.03). The predictive model including these variables showed good accuracy for predicting ED (areas under the curve 0.69 and 0.72, respectively). However, DCAs showed no greater clinical benefit regarding identifying which patients should actually be screened for ED using these variables versus screening all patients with LUTS. Conversely, the net clinical benefit of the tested model was higher when predicting severe ED. As a limitation, we could not check prospectively the clinical impact of detecting ED in LUTS patients.
Given the importance of ED in terms of overall men's health, segregating patients to be investigated or not for ED according to the traditional risk factors did not emerge more clinically useful than screening all patients presenting for LUTS.
Lower urinary tract symptoms (LUTS) are frequently associated with erectile dysfunction (ED). Patients presenting for LUTS only in the everyday clinical practice should always be screened for ED and managed accordingly.
目前,欧洲泌尿外科学会指南建议,只要临床怀疑存在下尿路症状(LUTS),就应对患者进行勃起功能障碍(ED)检查。
评估可能导致仅出现 LUTS 的男性需要进行临床评估的 ED 预测因素。
设计、地点和参与者:对在单中心门诊就诊且无 ED 既往诊断的 914 名男性的 LUTS 数据进行了分析。
所有患者均完成国际前列腺症状评分(IPSS)和国际勃起功能指数-勃起功能(IIEF-EF)问卷。
使用逻辑回归分析测试 ED 和重度 ED 的潜在预测因素。评估预测模型的准确性,并通过决策曲线分析(DCA)测试其临床获益。
中位基线 IPSS 评分为 12(7-19)。在 503 名(55%)患者中观察到提示未报告 ED 的 IIEF-EF 评分;其中 251 名(27%)男性患有重度 ED。在逻辑回归分析中,年龄(比值比 [OR]:1.04;p<0.001)、IPSS 评分(OR:1.04;p<0.001)、糖尿病(OR:2.37;p=0.02)和吸烟史(OR 1.36;p=0.03)与未报告 ED 相关,在考虑体重指数、高血压、其他心血管疾病和血脂异常后。同样的因素与重度 ED 相关(均 p≤0.03)。包含这些变量的预测模型对 ED 的预测具有较好的准确性(曲线下面积分别为 0.69 和 0.72)。然而,DCA 显示,与筛查所有出现 LUTS 的患者相比,使用这些变量识别哪些患者实际上需要筛查 ED 并不能带来更大的临床获益。相反,在预测重度 ED 时,测试模型的净临床获益更高。作为一个局限性,我们无法前瞻性地检查在 LUTS 患者中检测 ED 的临床影响。
鉴于 ED 在男性整体健康方面的重要性,根据传统危险因素对患者进行 ED 检查或不检查,并不比筛查所有出现 LUTS 的患者更具有临床意义。
下尿路症状(LUTS)常与勃起功能障碍(ED)相关。在日常临床实践中仅出现 LUTS 的患者应始终筛查 ED 并进行相应治疗。